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To assess the multiple risk factors reported to be associated with onset of serious bacterial, fungal, viral,
and protozoal infections in renal allograft recipients, a retrospective study of all renal transplantations
performed at Yale-New Haven Medical Center from the inception of the transplantation program in
December, 1967, to December, 1975, was undertaken.
Ninety-six renal allograft transplants in 85 patients were available forevaluationduringthis study period.
Renal allograft recipients were evaluated for incidence of infection from time of transplantation until
transplant nephrectomy, death, or January 1, 1976. All infections were characterized by type of infection,
organism, site, and time of onset post-transplantation. Recipients with infections were also evaluated for
their donor type, living-related orcadaveric, age at time oftransplantation, granulocytopenia, corticosteroid
therapy, and rejection episodes.
There were 215 infections, 92 of which were defined as serious, in 78 ofthe 96 renal allograft recipients.
Eighteen renal allograft recipients had no infections. Granulocytopenia, but not rejection, correlated with
serious infections at some time in the patient's course. However, no significant temporal relationship
between serious infections and episodes ofgranulocytopenia or rejection could be established. Mortality rate
and incidence of serious infection was higher in the group receiving high dose corticosteroid therapy
compared with the group receiving lower doses ofcorticosteroids. The mortality rate in these 85 transplant
recipients was 33%. Seventy-four percent of these deaths were directly related to infection (24% of 85
patients).
INTRODUCTION
Serious bacterial, fungal, viral, and protozoan infections comprise the well-
documented causes of morbidity and mortality in the immunosuppressed patient
population [1-3]. Risk factors which predispose renal allograft recipients to their
infections have been suggested, but no unifyinghypothesis has beenestablished[4-9].
The present study, therefore, was undertaken to assess multiple riskfactors through a
retrospective evaluation of all renal transplantations performed at Yale-New Haven
Medical Center from the inception of the program in December, 1967, until
December, 1975. In particular, potential temporal relationships between episodes of
granulocytopenia, allograft rejection, and infection were evaluated.
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Population
One hundred and forty-eight renal allograft transplantations were performed in
135 patients at Yale-New Haven Medical Center between December, 1967, and
December, 1975. Thirty ofthe 148 renal transplants were performed on 29 patients in
the West Haven Veterans Administration Hospital and were not evaluated in the
present study. Also, the infectious complications in 21 patients with 22 of the
remaining 118 renal allografts could not be properly evaluated since documentation
of particular findings needed for the diagnosis of the infection (see definitions) was
not available in the hospital record or the post-transplant flow sheet. Therefore, 96
renal allografts performed in 85 patients were available for evaluation and comprise
the patient population of this retrospective study. All charts were evaluated from the
time oftransplantation until removal ofthetransplanted kidney, death, orJanuary 1,
1976, whichever occurred first.
Retrieval ofData
All data was retrieved according to the methods described by Feinstein for
retrospective chart analysis [10,11]. Thus, cases were excluded from analyses of
incidences ofparticular findings if the presence or absence of these findings were not
clearly documented. Therefore, the data presented represent the number of cases of
renal allograft recipients with positive findings in relationship to the number ofcases
when verifications of positive or negative findings could be made.
The data on each transplant recipient were obtained from two sources: the hospital
record and the immediate post-transplant flow sheets maintained by the renal
section. The following data were obtained for all patients: sex, age, and weight at
time of transplant, race, type of renal disease, donor type (cadaver or living related),
and date of transplant operation. In addition, white blood cell count with percent
polymorphonuclear leucocytes, blood urea nitrogen, creatinine, dosages of corti-
costeroids, azothioprine, actinomycin D, and anti-lymphocytic globulin (ALG), as
well as all diagnostic procedures including microbiology studies, chest roentgeno-
grams, renal scans, and biopsies were also evaluated.
All infectious complications which occurred duringeach post-transplant hospitali-
zation were documented as to etiology, site, and clinical course. Infections were
classified by the following criteria:
Symptomatic urinary tract infection. A single clean catch or catheter urine
specimen containing greater than 100,000 colonies per milliliter bacteria, in associa-
tion with clinical signs of infection which included fever, dysuria, urgency, and
frequency.
Lower respiratory tract infection. Patients with any four of the following six
criteria were classified as having lower respiratory tract infection: (1) temperature
>99.40F orally or 1000F rectally; (2) cough, purulent sputum; (3) chest roentgeno-
gram demonstrating alveolar or interstitial infiltrates that did not clearwith vigorous
diuresis or dialysis; (4) a clinical history not compatible with pulmonary emboliza-
tion; (5) isolation of a single or predominant pathogenic organism(s) from a tracheal
aspirate or pulmonary biopsy specimen; or (6) isolation of the same organism from
cultures of blood and sputum in close temporal proximity.
Septicemia. Septicemia was diagnosed if the identical organism(s) was present in
two or more blood culture sets obtained at separate time intervals.
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Surgical-abdominal wound infection. Any surgical wound with purulent drainage
with or without a positive culture was considered infected. Positive cultural findings
in serous drainage was considered an infection if accompanied by tenderness and
fever with no other apparent source of infection. This was classified as a urinary
cutaneous fistulainfection ifthedrainagefluid was urine. Arteriovenous fistulas were
considered a surgical infection.
Peritonitis. The diagnosis of peritonitis was madewith orwithout positive cultures
if there were positive abdominal findings on physical exam and more than 300
polymorphonuclear leucocytes in the peritoneal fluid.
Perinephric abscess. A perinephric abscess was documented byfindings at surgical
exploration and/or by abdominal arteriography.
Hepatitis. Hepatitis was diagnosed in any patient with abnormal liver function
studies and compatible physical findings. A positive hepatitis B surface antigen was
not necessary for the diagnosis.
Meningitis. Patients withfungal or bacterial organisms isolatedfromcerebrospinal
fluid cultures or with cerebrospinal fluid pleocytosis and fever were classified as
having meningitis.
Pericarditis. Pericarditis was diagnosed bythe presence ofa pericardialfriction rub
and the recovery of microorganisms from culture of pericardial fluid.
Endocarditis. Patients with one or more ofthe following criteria were classified as
having endocarditis: endocarditis at autopsy; a pathologic murmur, i.e., a murmur
in diastole, a new or changing murmur, and/orsustained bacteremia, defined asfour
or more blood cultures positive during a period of evaluation for sepsis without an
apparent, alternative site of intravascular infection.
Skin infection. Patients with purulent drainage or apositive culture obtainedfrom
the involved area plus any two of the following criteria: heat, redness, swelling, or
tenderness, were classified as having an infection of the skin. Skin infections were
sub-divided into four groups: superficial skin infections including cellulitis and IV
site infection, Herpes simplex, Herpes zoster, and skin abscesses.
Unexplainedfever. An unexplained fever was defined by a temperature >99.40F
orally or 1000F rectally without evidence of graft rejection and with no source or
infecting agent identified within five days. Unexplained fever was not considered to
be an infection in this analysis.
Asymptomatic bacteriuria. Asymptomatic bacteriuria was defined as two or more
clean catch or catheterized urine specimens containing >100,000 colonies per
milliliter of a single species of bacteria forfemales and >10,000 colonies permilliliter
of a single species of bacteria for males without clinical symptoms. Asymptomatic
bacteriuria was not considered an infection in this analysis.
Serious infections. Pneumonia, meningitis, peritonitis, pericarditis, endocarditis,
septicemia, perinephric abscess, disseminated varicella and nocardia, suppurative
parotitis, and all urinary tract or wound infections associated with a concomitant
bacteremia with the same organism were considered serious infections.
Risk Factors Evaluated
Rejection episodes. An acute rejection episode was defined by the criteria used by
the renal section at this institution and include a decrement in renal function, fever,
tenderness at graft site, abnormalities in technetium 99 blood flow scan and renal
biopsy. Only those instances in which no other cause could be found to explain the
above abnormalities, and where immunosuppressive therapy was altered to treat
rejection, were included in this analysis as rejection episodes.
515Severe granulocytopenia. Severe granulocytopenia was defined as a polymorpho-
nuclear leucocyte cell count equal to or less than 1000 cells/mm3 blood on two
sequential differential white blood cell counts.
Relative granulocytopenia. A polymorphonuclear leucocyte cell count greater than
1000 and less than or equal to 2000 cell/mm3 blood on two sequential differential
white blood cell counts was considered to be relative granulocytopenia.
Granulocytopenia. Granulocytopenia was defined as a polymorphonuclear leuco-
cyte cell count of less than 2000 cells/mm.3 This included both severe and relative
granulocytopenia.
Corticosteroid therapy. High dose corticosteroid therapy was defined as a steroid
dose equivalent to one or more milligrams per kilogram per day ofprednisone for 27
ofthefirst 60 days aftertransplantation. This definition was chosen since, as noted by
Finkelstein and Black [7] in their analysis of a segment of this population, one
episode of acute rejection, to which the patient responded successfully, usually
involved high dose (1 mg/kg prednisone) corticosteroid therapy for 26 or fewer days
within the first 60 days.
Age and allograft. Patients' age at time of transplantation, and type of allograft,
i.e., cadaver, or living-related, were also correlated with incidence of infection.
Data Analysis
The incidence of infection was based on the observation of the number oftimes a
particular infection occurred divided by the total number ofrenal allograft recipients
(96 renal allografts). Mortality data is calculated from the total number ofpatients in
the analysis (85 patients). Statistical significance was determined by chi square
analysis using Yates correction factor for small numbers [12].
RESULTS
Population
In this study population, 96 renal allografts were performed in 85 patients, eleven
of whom received two renal allografts. There were 21 living-related donors and 75
cadaveric donors. Patients ranged in age between one and 56 years. There were 51
males and 34 females. Eight males and three females received two renal allografts.
The population included 61 Caucasians, 20 Blacks, two Hispanic and two Asian
patients.
Primary renal diseases included 31 patients with chronic glomerulonephritis, 7
patients with malignant hypertension, 5 patients with chronic pyelonephritis, 5
patients with interstitial nephritis, and 2 patients each with systemic lupus erythema-
tosis, diabetic nephropathy, Wegener's granulomatosis, obstructive uropathy, and
hereditary medullary cystic disease. Single cases ofuric acid nephrocalcinosis, rapidly
progressive glomerulonephritis, renal cell carcinoma, and congenital multicystic
disease were also reported. In 20 patients, the primary renal disease was not known.
Infections
Two hundred and fifteen infections were documented in 78 of the 96 renal
allografts. Of the 215 infections, 92 were considered to be serious as previously
defined. These occurred in 45 of the 78 allografts who had some type of infection,
whereas 33 of these 78 recipients had non-serious infections and 18 renal allograft
recipients (17 patients) had no infection throughout their course. Figure 1 demon-
strates that in every age group there was a higher percentage of serious infections in
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FIG. 1. Percent of allograft recipients with serious infections compared to donor type and age of recipient at
transplantation. (Figure in parenthesis represent the number of allograft recipients in each group).
patients with cadaveric donors. In addition, patients with cadaveric kidneys under
the age of 10 and over 40 had a greater percentage of infections compared with
cadaveric recipients between the ages of 10 and 40. Although this finding is not
statistically significant (0.1 <p < 0.2), the numbers ofpatients less than 10 years and
greater than 40 years of age were small. The urinary tract was the most commonsite
of infection in our population of renal allograft recipients. However, among the
serious infections, septicemia and lower respiratory tract infection were most
frequent, with 34 respiratory tract infections and 28 episodes of septicemia docu-
mented. Other serious infections included hepatitis in 4 patients, meningitis in 3
patients and pericarditis and efidocarditis in one patient each (Table 1). There were
five episodes of unexplained fever and 7 of asymptomatic bacteriuria.
The etiology of these infections is shown in Table 2. Bacterial organisms were the
major pathogens and caused approximately 80 percent ofinfections in renal allograft
recipients. Viral and fungal organisms each caused approximately six percent of
infections. Mixed bacterial and fungal agents accounted for three percent of the
infections. In five percent no causative agent could be found.
Infectious organisms cultured from the urinary and respiratory tracts, blood,
surgical abdominal wound, urinary cutaneous fistula, perinephric abscess, and
central nervous system are shown in Fig. 2. Most urinary tract infections were caused
by gram-negative bacilli, predominantly E. coli. Bacteria were responsible for 23 of
31 lower respiratory tract infections. In addition, two patients developed pneumo-
cystic carinii pneumonia. Single cases ofaspergillosis, nocardiosis, and an unknown
yeast were observed. Listeria monocytogenes and Staphylococcus aureus were the
most common organisms isolated from blood and were each responsible for 20
percent of bacteremic episodes. The six episodes of Listeria monocytogenes sepsis
occurred within a 12-month time period in this hospital. An extensive epidemiologic
evaluation revealed no common source, although four of the six clinical infections
were ofthe same subgroups. Sixty-seven percent ofabdominal wound infections were
caused by mixed gram-negative and gram-positive bacteria, and thirty percent were
of staphylococcal origin. All urinary cutaneous fistula infections were of mixed
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TABLE I
Types of Infections in 96 Renal Allografts at Y-NHH
December 1967-December 1975
No. No.
Site Episodes Allografts Percent*
Urinary tract 62 38 40
Respiratory tract
Upper 3 3
Lower 31 23
Total 34 25** 26
Septicemia 28 21 22
Surgical-abdominal wound 24 23 24
Skin
Herpes zoster 2 2
Superficial 5 4
Herpes simplex 6 6
Abscess I1 9
Total 24 19** 19
Intra-abdominal
Perinephric abscess 5 5
Peritonitis 6 6
Total 11 11 12
Urinary cutaneous fistula 8 8 8
Other wounds
Femoral, hip, thoracotomy 4 4
C-section, wrist, fistula 4 4
Total 8 8 8
Hepatitis 4 4 4
Gastrointestinal
Esophagitis I I
Proctitis I I
Suppurative parotitis 2 2
Total 4 4 4
CNS-meningitis 3 3 3
Cardiac
Pericarditis 1 I
Endocarditis 1 I
Total 2 2 2
Other
Disseminated varicella I I
Disseminated nocardia I I
Total 2 2 2
ENT-Maxillary sinusitis 1 1 I
Unexplained fevert 5 5 5
Asymptomatic bacteriuriat 7 7 7
*Number of allografts with this infection/total number of allografts
**Allograft recipient had infection in more than one category contained under this heading
tNot considered on analvsis as infectionsINFECTION IN RENAL TRANSPLANT RECIPIENTS
TABLE 2
Etiologic Agents Causing Infections'in 96 Renal Allograft Recipients
Etiology (No.)
Total P. Bact. Un-
Site of Infection No. Bact. Fungal Viral Carinii Fung. known
Urinary tract 61 62
Respiratory 34 20 3 3 2 3 3
Septicemia 28 26 2
Surg-abdominal wound 24 24
Skin 24 12 3 8 1
Urinary cutaneous fistula 8 8
Other wounds 8 7 1
Peritonitis 6 5 1
Perinephric abscess 5 5
Hepatitis 4* 2 2
Meningitis 3 1 1 1
Suppurative parotisis 2 1 1
Pericarditis 1 1 I
Endocarditis I
Disseminated
varicella 1 I
nocardia 2 1
Esophagitis 1 I
Proctitis 1 I
Maxillary sinusitis I
TOTALS 215 173 12 12 2 11
*Two patients were hepatitis B surface antigen positive, one was negative, and one was not tested. Cytomegalovirus
and toxoplasma titers were not available for any of the four recipients with hepatitis.
bacterial origin composed of gram-negative bacilli and Staphylococcus aureus.
Infections in this patient population were analyzed relative to rejection episodes,
granulocytopenia, and high dose steroids.
Infections-Rejections
The time of all documented infections and rejections in the post-transplant period
is shown in Fig. 3. The highest incidence of both infections and rejections occurred
within the first sixty days after transplantation. However, after the first post-
transplantation year transplant rejection became a relatively minor contribution to
morbidity, whereas late onset infection persisted and was a major factor in the
morbidity and mortality, i.e., 48% of the surviving recipients in this study experi-
enced a documented infection after one year while only 7% had a rejection episode.
Two of the 96 recipients experienced a severe rejection episode within the first 72
hours and underwent transplant nephrectomies. In the remaining 94 recipients the
number of serious infections were compared between 73 recipients with two or less
rejection episodes and 21 recipients with three or more rejection episodes duringtheir
clinical course. Twenty-nine of the 73 recipients with two or fewer rejection episodes
had 65 serious infections (2.2 infections per patient) while 12 of 21 recipients with
three or more rejection episodes had 31 serious infections (2.6 infections per patient).
The differences between the two groups was not statistically significant (p2 0.20).
Infection-granulocytopenia. Seven of the 94 evaluable recipients had episodes of
severe granulocytopenia (granulocytes < 1000/mm3) and 13 recipients had an
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FIG. 2. The infectious agents causing infection at different sites in the 78 renal allograft recipients who developed
infection. Within each site the percent of infections caused by each organism is roughly calculated. Microorganisms
causing infection at additional sites listed in Table 2 are not included in this figure thus the total number of infections
does not equal 215. Number in parenthesis indicate the actual number of infections in the 78 renal allograft recipients at
each site.
episode of relative granulocytopenia (granulocytes > 1000 < 2000/mm3) (Fig. 4).
Nineteen of the 20 granulocytopenia recipients had received cadaveric allografts. Of
the seven recipients with severe granulocytopenia, 5 (71.4%) had a total of 15 serious
infections. Ten of the 13 patients (77%o) with relative granulocytopenia experienced
28 serious infections post-transplantation. Twenty-five (34%) of the 74 non-
granulocytopenic recipients had 49 documented serious infections at some time in
their evaluated course.
The incidence of serious infection in severe granulocytopenic recipients compared
with the non-gra-nulocytopenic group was not significant (0.10 > p < 0.20). This may
be related to the small number of allograft recipients in the severe granulocytopenic
group, since the incidence of serious infection in the relative granulocytopenic
recipients compared with the non-granulocytopenic group was significant (p <0.01),
as was the incidence when both severe and relative granulocytopenic groups were
combined and compared with the non-granulocytopenic group. There was no
significant difference in the number of serious infections between the severe and
relative granulocytopenic groups.
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FIG. 3. Time of occurrence ofall documented infections and rejections in the post transplantation period. Number in
parenthesis equals the percentage of allograft recipients with the entity. Percentage equals number of allografts with the
entity/total number of allografts evaluable for the entity.
To determine whether a temporal relationship existed between granulocytopenic
and rejection episodes with infections, the separate incidences of granulocytopenias
and rejections occurring for the five days preceding and the five days following the
diagnosis of infection were compared. All infections inthe early postoperative period
and all serious infection throughout the clinical course were included in this analysis.
100
75 ~ ()///
% of Allografts
who developed
serious infection
50
25
0
Severe Relative Non
Granulocytopenia Gronulocytopenia Granulocytopenia
FIG. 4. Percentage ofallograft recipients whodeveloped serious infection relative to episodes ofgranulocytopenia at
anytime post transplantation. Number in parenthesis is the total number of allografts in each group.
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IITwenty renal allograft recipients, of the 94 evaluated, had 32 episodes of granulo-
cytopenia during their clinical course. Nineteen of these recipients had at least one
episode of granulocytopenia during the early postoperative period. In this period 10
of the 19 recipients with granulocytopenia had 21 infections temporally associated
with the granulocytopenia episode. Fifty-nine ofthe remaining 75 allograft recipients
had 113 infections not temporally associated with a granulocytopenic episode in this
period. This difference was statistically significant (p = <0.05) with a higher
incidence of infections in those patients who were not granulocytopenic. Eight of 20
patients with granulocytopenia at some time in their course rather thanjust the early
postoperative period had 15 serious infections temporally associated with granulocy-
topenia. The remaining 12 patients had no incidence of temporally related serious
infection.
In evaluating the association between infections and rejection episodes, we found
that 26 of the 94 allograft recipients studied had 42 infections in the five-day period
preceding and/or following a rejection episode. Fifty-four renal allografts experi-
enced 76 episodes of rejection without an associated infection. Fourteen recipients
had no rejection episode during this period, and nine of these experienced infection.
Of the 96 allograft recipients initially in the study, 39 were evaluated for any
association between serious infection and low or high dose corticosteroid therapy.
The remaining 57 patients were excluded because of transplant nephrectomy,
discharge from hospital prior to 60 days, or death. High dose therapy was adminis-
tered to 21 of these 39 recipients while 18 received low dose steroids.
Serious infections occurred in 16 of the recipients on high dose therapy (75%) and
11 of the low dose steroid group (60%). Although the small number of patients
receiving steroids precluded a statistical analysis of morbidity and mortality with the
high and low dose groups, we noted that the mortality rate in the group on high dose
steroid was 33%, but only11% in the low dose group.
At the conclusion of the study period 82 of the 85 patients remained available for
evaluation. The status ofthree was unknown. Twenty-nine ofthese patients exhibited
stable renal function(creatinine< 2.5 mg%o), 26 patients had returned to dialysis, and
27 patients died. Of the 27 deaths, 21(74%) were attributable to infectious complica-
tions. Table 3 presents the sites and the organisms responsible for these fatal
infections. Pneumonias accounted for the major cause of death either as single fatal
events or as major parts of septic events. Gram-negative pathogens accounted for
eight deaths either as single isolates causing pneumonia or as mixed flora in
combined abdominal and respiratory tract infections. Ofthe opportunistic infections
pneumocystis carinii, aspergilla species, and nocardia accounted for two deaths each
while disseminated candidiasis was responsible for one death.
DISCUSSION
Finkelstein and co-workers at this institution have emphasized the need to explore
further the role ofpredisposing risk factors to negative outcomes in renal transplants
in view of high reported patient mortalities and graft failure rates [7]. The overall
mortality rate in our series was 33% and approximately the mortality rate found by
Anderson et al. [4] and Gurland et al. [14] though it is higher than a recently reported
series from Belfast [13].
In an attempt to isolate specific potential risk factors in the present study each
transplant recipient was evaluated according to stricter definitions of leukopenia and
infection than have been employed in previous studies by others. Prolonged high
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TABLE 3
Type of Infection and Organism(s) Leading to Death in 21 Renal Allograft Recipients
Type of Infection POD* Causative Organism(s)
Pneumonia 60 Pneumocystis carinii
Pneumonia 51 E. coli
Pneumonia 533 Aspergilla
Pneumonia 69 Staphylococcus aureus
Pneumonia 61 Pneumocystis
Pneumonia 103 Mixed gram-negative organisms
Pneumonia 192 E. coli
Pneumonia 138 Nocardia
Peritonitis 716 Mixed bowel flora
Peritonitis 73 Mixed bowel flora
Peritonitis 948 Mixed bowel flora
Peritonitis 118 Mixed bowel flora
Bacteremia 747 E. coli
Bacteremia 1066 Listeria monocytogenes
Perinephric abscess 35 Staphylococcus aureus
Perinephric abscess 24 Enterobacter
Bacteremia perinephric abscess 46 Candida
Disseminated zoster 185 Varicella
Disseminated nocardia 215 Nocardia
Fungemia 73 Aspergilla
Bacteremia Peritonitis 32 Mixed bowel flora
*POD: Postoperative day
dose corticosteroid therapy as a potential risk factor was similarly analyzed for a
correlation with infection and mortality. The infections that occurred in ourseries of
recipients were similar to those found in other studies [8,15,16]. In general the most
common early postoperative infections were from the urinary tract and these
represented 29% of the 215 infections in the series. What we defined as serious
infections represented 42% of all infections (92/215). In this group there was a 30%o
incidence of sepsis and a 34% incidence of pneumonia. Thus, like Turcotte [16], we
found pneumonia to be a common event associated with a high mortality rate. Gram-
negative bacteria were the most common pathogens in these infections.
As others have reported, we found a correlation between granulocytopenia and
serious infections. Anderson et al. [14], using a rather broader definition of leuko-
penia (total white blood cells of less than 3000/mm3 for a minimum of three
consecutive determinations on different days) were unable to demonstrate a signifi-
cant temporal association between episodes of infection and episodes ofgranulocy-
topenia. In a smaller study, Simmons et al., using an equally broad definition,
observed 18 episodes ofleukopenia in a group of9 patients with a correlation noted
in 13 infections [5]. A further restriction of this study, however, was a minimal
survivor time of all 98 patients ofat least 250 daysfromtransplantation. With regard
to evaluating leukopenia further as a risk factor we chose parameters that took into
account Bodey's and his co-workers correlation between increased incidence of
infection and granulocyte count <1000/mm3 [17]. In ourseries 20 allograft recipients
had 32 granulocytopenic episodes that could be divided into severe granulocytopenia
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<1000/ mm3 and relative granulocytopenia (1000-2000 mm3). Using these -more
restrictive criteria, we found that onlv 8 of thcse 32 neutropenic episodes were
temporally associated with serious infectioni. IThese observations fail to inidicalte a
temnporal association between severe granulocytopenia and infection alone, even
though these 20 allograft recipients in the study with one or more episode of
granulocytopenia did have a higher incidence of scerious infection thaln those
recipienits who were never granulocytopenic in thcir clinical course (p < 0.01).
The observation that rejection predisposes to infection through alteration in
humoral immunity and in some cases through rejection-mediated leukopenia or
following vigorous anti-rejection therapy is frequently stated in the literature
[4,18-20]. In an attempt to document this relationship in our series, the incidence of
infection in 21 renal allograft recipients who had three or more rejection episodes at
any time in their clinical course was compared with the incidence of infection in the
73 recipients who experienced two or fewer rejections. No statistical significance was
found between these groups. However, in a prior study of this patient population,
Finkelstein et al. [7] had reported that a second rejection episode within the first two
months post-transplantation predisposes to increased mortality. These authors
report 9 deaths or transplant nephrectomies in 12 patients with greater than two
rejections while only 9 of 27 patients with no rejections died or underwent transplant
nephrectomy. This data is at variance with the Belfast series, which had a lower
rejection rate overall, and no deaths caused by infection within the first 60 days after
transplantation. There were, however, two later deaths caused by infections which
were associated with leucopenia brought about by anti-rejection therapy [13].
Nonetheless, our data appears comparable with the general experience reported in
this country and Europe with approximately a 35% mortality rate associated with
serious infections [4,14]. With alteration in the approach to immunosuppressive
therapy there have been conflicting and changing data on the role of high dose
steroids as a putative risk factor. The 39 allograft recipients we were able to evaluate
represented a population too small to be evaluated statistically. However, in the
present series, recipients treated with high dose steroids did have a higher mortality
rate (33%) secondary to infection than the low dose group (I 1%).
In conclusion, analysis of our renal allograft recipient population did not establish
significant temporal relationships between the potential risk factors, leucopenia,
multiple rejection episodes, high dose corticosteroid therapy, and serious infections.
Mortality rates associated with serious infections were definitely higher in those
patients who experienced any ofthe assessed risk factors at some time in their course.
A patient profile that includes: (I) age less than ten years or greater than 40 years;
(2) a cadaveric allograft, and (3) more than two rejection episodes with inherent high
dose immunosuppressive therapy, increased the risk of serious infections and
mortality. No attempt was made in this study to evaluate tissue typing and antigen
matches of the cadaveric recipients with the risks analyzed since this information was
not standardized throughout the time period studied. This data and data on patients
who receive anti-lymphocytic globulin therapy may further delineate patients at
greater risk for serious infections and unsuccessful outcomes.
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